Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) ...
Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...
EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) (“EOM”) an innovative biotechnology company focused on developing transformative treatments for chronic inflammatory conditions and debilitating retinal ...
Explore how nutrition plays a crucial role in cancer prevention, treatment, and recovery, emphasizing the power of a balanced diet.
Detailed price information for Vistagen Therapeutics Inc (VTGN-Q) from The Globe and Mail including charting and trades.
AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
3don MSN
Therapies that target specific type of cell death may be an effective avenue for cancer treatment
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...
News-Medical.Net on MSN
Study highlights potential of ferroptosis-based approaches to treat cancer
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback